Missing/wrong data?
Log in to edit
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
scientific article published on 4 June 2019
Author/s
author: Ted Michael Burns, Renato Mantegazza, E. Sally Ward, Andrzej Szczudlik
Work details
Publication date
June 4, 2019
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.